Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Leukemia & Lymphoma
|
September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse
Preetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
British Journal of Haematology
|
February 6, 2016
Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes
Preetesh Jain, Hagop Kantarjian, Koji Sasaki, et al.
Oncotarget
|
March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
British Journal of Haematology
|
May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)
Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex
Uri Rozovski, David M Harris, Ping Li, et al.
The American Journal of Surgical Pathology
|
June 8, 2023
Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features
Mahsa Khanlari, Huan Mo, Do Hwan Kim, et al.
Annals of Hematology
|
March 21, 2018
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia
Maliha Khan, Tariq Muzzafar, Hagop Kantarjian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 25, 2019
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage
Uri Rozovski, David M Harris, Ping Li, et al.
Haematologica
|
May 14, 2016
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis
Koji Sasaki, Hagop Kantarjian, Elias Jabbour, et al.
Molecular Cancer Research : MCR
|
March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
Uri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Leukemia & Lymphoma
|
September 6, 2013
Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse
Preetesh Jain, Hagop Kantarjian, Keyur Patel, et al.
British Journal of Haematology
|
February 6, 2016
Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes
Preetesh Jain, Hagop Kantarjian, Koji Sasaki, et al.
Oncotarget
|
March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
British Journal of Haematology
|
May 23, 2018
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL)
Preetesh Jain, Jorge Romaguera, Samer A Srour, et al.
Molecular Cancer Research : MCR
|
January 29, 2017
Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex
Uri Rozovski, David M Harris, Ping Li, et al.
The American Journal of Surgical Pathology
|
June 8, 2023
Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features
Mahsa Khanlari, Huan Mo, Do Hwan Kim, et al.
Annals of Hematology
|
March 21, 2018
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia
Maliha Khan, Tariq Muzzafar, Hagop Kantarjian, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 25, 2019
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage
Uri Rozovski, David M Harris, Ping Li, et al.
Haematologica
|
May 14, 2016
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis
Koji Sasaki, Hagop Kantarjian, Elias Jabbour, et al.
Molecular Cancer Research : MCR
|
March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
Uri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.
Page
of 18